<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1615816415302394&amp;ev=PageView&amp;noscript=1">

NEWS & INSIGHTS

Discover the valuable insights our consultants provide. Subscribe to our Insights blog to receive email alerts whenever we post something new!

Medical Affairs Leadership Guided Discovery | SVA

Medical Affairs Leadership Guided Discovery



Medical Affairs is a critical function in emerging life science companies operating at the intersection of the science, the medical community serving patients, and the business – and its role is essential in enabling patient success on emerging treatment options.

This function is responsible for several key activities including early market intelligence, pre-commercialization awareness, and post-approval support.

Medical Affairs Issues

The problem is Medical Affairs often evolves based on experience and opinions of individuals without a well-formed functional strategy and roadmap. This can lead to the function being constructed without a clear understanding of its strategic intent, priorities, and alignment among cross-functional stakeholders.

As a result, the organization may miss opportunities for Medical Affairs to contribute value early, and non-medical people rarely understand the full impact Medical Affairs can bring to the organization, medical community, and patients. How many times have you heard executives question the value of Medical Affairs activities…especially post approval?

sva-life-sciences-insights-blog-medical-affairs-and-performanceINSIGHT: Medical Affairs Impact and Performance

Leadership Guided Discovery

To solve these problems, SVA Life Sciences offers a Leadership Guided Discovery engagement for Medical Affairs.

This service features two workshops that help companies assemble a Medical Affairs timeline with underlying assumptions, milestones, and decision gates.

The workshops provide a clear understanding of key decisions and priority activities, helping companies to plot their Medical Affairs’ investments and expected outputs over the next two to three years.

Benefits of Leadership Guided Discovery

The benefits of the Leadership Guided Discovery include the development of an initial Medical Affairs value proposition for alignment and endorsement by the senior leadership team.

The roadmap of priorities and options for investing in and fulfilling priority activities provides a clear understanding of what needs to be done and when. The initial organizational design model helps companies consider their options for hiring and which Medical Affairs capabilities are needed and when.

SVA Life Sciences’ Leadership Guided Discovery is a valuable tool for emerging life science companies looking to build or enhance their Medical Affairs function.

  • If you haven't made your first Medical Affairs hire, the Leadership Guided Discovery provides a foundation for initial thinking about the mission, priorities of the function, and opportunities to act.
  • If you're a Medical Affairs leader, SVA Life Sciences can serve as your thought partner, helping you formulate strategies and plans for senior leadership approval.

sva-life-sciences-leadership-guided-discovery-advanced-preparation-for-your-1st-product-lanuch-2022INSIGHT: Leadership Guided Discovery - Advanced Preparation for Your 1st Product Launch

Learn More About Leadership Guided Discovery

If you're interested in learning more about the Leadership Guided Discovery, contact SVA Life Sciences for a 30-minute information exchange to discuss your situation. We will be happy to share what we've learned and experienced with other organizations like yours.

Request More Information

© 2023 SVA Life Sciences

Share this post:

Authored by: Andrew DeMarco

Authored by Andrew DeMarco

Andrew is a Principal with SVA Consulting, LLC, a member of the SVA family of companies. With over 20 years of business and consulting experience, Andrew has a well-honed ability to help leaders and their teams make sense of complex problems, identify solutions and drive meaningful change.